Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan in exercise-induced pulmonary arterial hypertension
NCT01338636Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2008
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ambrisentan in pulmonary arterial hypertension (PAH), sponsored by Brigham and Women's Hospital. Started Sep 2008; status: completed.
02
Drugs
ambrisentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01338636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01338636.